Skip to main content
SpringerLink
Log in

Gentamicin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration (CVVHDF)

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. D’Arcy DM, Casey E, Gowing CM, Donnelly MB, Corrigan OI (2012) An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration. BMC Pharmacol Toxicol 13:14. doi:10.1186/2050-6511-13-14

    Article  PubMed Central  PubMed  Google Scholar 

  2. Petejova N, Zahalkova J, Duricova J, Kacirova I, Brozmanova H, Urbanek K, Grundmann M, Martinek A (2012) Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients. J Chemother 24(2):107–112

  3. Winter ME (2010) Basic clinical pharmacokinetics. Lippincott Williams and Wilkins, Philadelphia

    Google Scholar 

  4. Goncalves-Pereira J, Martins A, Povoa P (2010) Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose. Clin Microbiol Infect 26:1258–1263

    Article  Google Scholar 

  5. Roberts JA, Lipman J (2006) Antibacterial dosing in intensive care. Clin Pharmacokinet 45(8):755–773

    Article  CAS  PubMed  Google Scholar 

  6. Fernández de Gatta MM, Martin-Suarez A, Lanao JM (2013) Approaches for dosage individualisation in critically ill patients. Expert Opin Drug Metab Toxicol 9(11):1481–1493

  7. de Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R (2014) Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen. Intensive Care Med 40:998–1005

Download references

Acknowledgments

The authors acknowledge the tireless commitment of the ICU nursing staff to data collection, ongoing research and patient care.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Ethical approval for this study was obtained from the Joint Hospitals Ethics Committees (St James Hospital/Adelaide and Meath Hospital Dublin, incorporating the National Children’s Hospital Ref. No. 041007/7704). Authorisation was obtained from the Irish Medicines Board. Written informed consent to participate and publish (predominantly consent by proxy) was obtained in compliance with the Helsinki Declaration.

Author information

Authors and Affiliations

  1. School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland

    Deirdre M. D’Arcy & Owen I. Corrigan

  2. Pharmacy Dept., Tallaght Hospital, Dublin, Ireland

    Evelyn Deasy & Caitríona M. Gowing

  3. Intensive Care Medicine, Tallaght Hospital, Dublin, Ireland

    Maria B. Donnelly

Authors
  1. Deirdre M. D’Arcy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Owen I. Corrigan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Evelyn Deasy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Caitríona M. Gowing
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria B. Donnelly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Deirdre M. D’Arcy.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Table 1

(DOCX 16.6 kb)

Supplementary Table 2

(DOCX 15 kb)

Supplementary Table 3

(DOCX 20.5 kb)

Supplementary Table 4

(DOCX 15 kb)

Supplementary Fig. 1

Multiple gentamicin concentrations in a dosage interval for seven patients treated concurrently with gentamicin and CVVHDF therapy. ■ patient 1, □ patient 2, ▲ patient 3, ∆ patient 4, ● patient 5, ○ patient 6, × patient 7 (GIF 80.9 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

D’Arcy, D.M., Corrigan, O.I., Deasy, E. et al. Gentamicin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration (CVVHDF). Eur J Clin Pharmacol 71, 377–378 (2015). https://doi.org/10.1007/s00228-014-1765-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-014-1765-z

Keywords

Search

Navigation